| Product Name | MF | CAS | Details |
|---|
| α-Glucosidase-IN-8 | C19H20FN3O2 | 2448345-96-6 | Details |
| L-I-OddU | C8H9IN2O5 | 207920-87-4 | Details |
| PDE4-IN-9 | C15H12N4O3S | 2519450-32-7 | Details |
| NMDA receptor modulator 4 | C13H9F3N2O3S | 2758256-71-0 | Details |
| BChE-IN-14 | C24H29N | 2700896-78-0 | Details |
| Anticandidal agent-1 | C19H22O5 | 2548852-85-1 | Details |
| SLK/STK10-IN-1 | C17H13ClN2O3 | 264210-49-3 | Details |
| hCAIX/XII-IN-2 | C19H14N2O4 | 2414629-82-4 | Details |
| Antitubercular agent-21 | C15H22N6OS | 2412142-93-7 | Details |
| HDAC1/MAO-B-IN-1 | C18H17ClN2O2 | 2759855-37-1 | Details |
| CAXII-IN-1 | C13H7Cl2NO3S | 2479918-59-5 | Details |
| KCa2 channel modulator 1 | C16H15ClFN5 | 1019106-73-0 | Details |
| S07-2001 | C15H17N3O4S | 1197904-57-6 | Details |
| LDHA/PDKs-IN-2 | C17H20N2O5 | 2490699-44-8 | Details |
| SCH-42354 | C16H23NO3S2 | 144505-58-8 | Details |
| NBD-125 | C19H18ClNO2 | 2367641-24-3 | Details |
| Myt1-IN-3 | C18H19N5O2 | 2719793-54-9 | Details |
| RIPK1-IN-15 | C19H19N3O2 | 2755704-34-6 | Details |
| Androgen receptor antagonist 4 | C22H18ClN | 354815-43-3 | Details |
| CBR-3465 | C16H18FN3O2S | 2225883-59-8 | Details |
| Tubulin polymerization-IN-37 | C19H20N2O4 | 2011784-92-0 | Details |
| Vin-F03 | C22H29N3 | 2180917-11-5 | Details |
| Apoptotic agent-1 | C12H6ClN5O2S | 2490538-26-4 | Details |
| DPP-4-IN-2 | C18H18N6O | 2133900-95-3 | Details |
| Xanthine oxidoreductase-IN-1 | C18H20N4O2 | 2396612-00-1 | Details |
| ZINC12409120 | C20H16N4O2 | 1010888-06-8 | Details |
| Pirepemat fumarate | C15H17F2NO5 | 2251806-70-7 | Details |
| VU6010572 | C20H18FNO3 | 2126784-39-0 | Details |
| Polvitolimod | C13H14FN5O4 | 2389988-81-0 | Details |
| RXFP3 agonist 1 | C18H18ClN5 | 2752378-24-6 | Details |
| CD73-IN-9 | C14H11F2N5O2 | 2766565-88-0 | Details |
| COX-1/2-IN-3 | C14H8N2O8 | 2428387-82-8 | Details |
| Antibacterial agent 111 | C18H12N6S | 2448358-84-5 | Details |
| Elastase-IN-1 | C17H12N4O3 | 678152-73-3 | Details |
| Caprochlorone | C19H19ClO3 | 13878-10-9 | Details |
| S07-2009 | C16H19N3O5 | 1580241-55-9 | Details |
| HPK1-IN-24 | C19H14FN5 | 2294966-07-5 | Details |
| hMAO-B-IN-3 | C20H15NO4 | 2581113-51-9 | Details |
| Antibacterial agent 95 | C19H16ClNO3 | 2413006-48-9 | Details |
| ENMD-1068 hydrochloride | 2703451-51-6 | Details |
| Androgen receptor antagonist 3 | C22H18ClN | 353484-46-5 | Details |
| Antituberculosis agent-2 | C19H17NO4 | 2411741-01-8 | Details |
| HDAC6-IN-11 | C19H16N2O4 | 2409072-27-9 | Details |
| MAT2A-IN-4 | C18H16ClN3O | 2439272-57-6 | Details |
| S(-)-Bisoprolol | C18H31NO4 | 99103-03-4 | Details |
| MMP2-IN-1 | C15H13NO5S | 2764598-01-6 | Details |
| GABAA receptor agent 7 | C18H13ClN4O | 2376841-18-6 | Details |
| JMI-346 | C19H20N4O2 | 2091841-46-0 | Details |
| UC-1V150 | C16H17N5O4 | 927822-45-5 | Details |
| A1AR antagonist 5 | C17H15ClN4O | 1030509-01-3 | Details |
| TRβ agonist 3 | C20H25NO3 | 2411099-46-0 | Details |
| Aldose reductase-IN-5 | C18H15NO5 | 2480090-03-5 | Details |
| SSTR4 agonist 4 | C19H26N4O | 2747928-27-2 | Details |
| SDR-04 | C19H16N4O2 | 879593-54-1 | Details |
| HG122 | C15H13N5O5 | 1854976-77-4 | Details |
| Pim-1 kinase inhibitor 3 | C20H25N3O2 | 2801695-39-4 | Details |
| PXYC12 | C15H15N5O2S | 1112415-91-4 | Details |
| Dopamine D4 receptor antagonist-1 | C18H19ClN4 | 444724-92-9 | Details |
| CD73-IN-8 | C17H13ClN4O2 | 2763710-08-1 | Details |
| NMDA receptor modulator 5 | C14H11F3N2O3S | 2758256-97-0 | Details |
| B-Raf IN 7 | C15H16N6O3 | 2477725-07-6 | Details |
| ANO1-IN-3 | C20H17NO3 | 2494280-04-3 | Details |
| Anticancer agent 75 | C22H24N2O | 2414491-13-5 | Details |
| α-Glucosidase-IN-9 | C19H12N4OS | 735273-33-3 | Details |
| YXL-13 | C13H15BrN2O4 | 2415981-79-0 | Details |
| c-ABL-IN-2 | C21H20N4O | 2574593-54-5 | Details |
| Antitubercular agent-14 | C20H27ClN2 | 2408627-49-4 | Details |
| BRG1-IN-1 | C20H19FN2O | 2616813-99-9 | Details |
| HIF-1/2α-IN-2 | C16H11FN4O2S | 862974-22-9 | Details |
| As-358 hydrochloride | C18H32ClNO2 | 2374723-26-7 | Details |
| JMI-105 | C20H23N3O2 | 2227315-30-0 | Details |
| LANA-DNA-IN-1 | C19H14N4O2 | 2512847-06-0 | Details |
| PT4 | C18H14N4O2 | 1280738-47-7 | Details |
| IKK-IN-4 | C18H19N5S | 615529-94-7 | Details |
| AChE/BuChE-IN-2 | C20H18N2O2 | 1946008-31-6 | Details |
| Tubulin polymerization-IN-31 | C18H13ClFN3 | 2421121-79-9 | Details |
| PXYC13 | C15H15N5O2S | 1031940-69-8 | Details |
| ZL-Pin01 | C14H17ClN2O3S | 1047464-92-5 | Details |
| HBV-IN-25 | C18H14ClNO4 | 2161364-69-6 | Details |
| Gü2602 | C16H22N4O3 | 1627094-88-5 | Details |
| Factor VII-IN-1 | C15H10BrNO3 | 244206-28-8 | Details |
| Neuraminidase-IN-6 | C16H16N4O2S | 2738526-22-0 | Details |
| Adenosine receptor antagonist 3 | C16H14N6S | 2400864-80-2 | Details |
| UCSF648 | C15H19ClN2O2S | 2637090-55-0 | Details |
| Antiparasitic agent-6 | C19H15N3O3 | 2253996-73-3 | Details |
| mGluR2 modulator 2 | C20H22FN3 | 1004614-86-1 | Details |
| PDE4-IN-8 | C18H22BNO4 | 2415085-45-7 | Details |
| CD73-IN-10 | C15H13F2N5O2 | 2766565-91-5 | Details |
| CD73-IN-11 | C14H10F3N5O2 | 2766566-11-2 | Details |
| BChE-IN-7 | C21H24N2O2 | 2416910-85-3 | Details |
| TK4b | C21H22N2O2 | 2232890-81-0 | Details |
| RSK-IN-1 | C22H17NO2 | 2761698-77-3 | Details |
| HOE961 | C13H17N5O5 | 152819-48-2 | Details |
| PK9327 | C21H22N2S | 2413987-20-7 | Details |
| ERD03 | C21H25NO3 | 1377897-01-2 | Details |
| Anticancer agent 70 | C13H9Cl2N3O2S | 2521770-35-2 | Details |
| Ep vinyl quinidine | C20H24N2O2 | 101143-87-7 | Details |
| SARS-CoV-2-IN-18 | C20H14N2O3 | 184904-82-3 | Details |
| gp120-IN-1 | C15H18N2O4S | 5948-75-4 | Details |
| Xanthine oxidase-IN-5 | C18H16FN3O3 | 2276711-87-4 | Details |
| Product Total： Product Page： | ||||
| 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||